Ammonium Chloride
**Ammonium chloride** is a systemic and urinary acidifying agent used in veterinary medicine. * **Primary Uses:** Helps prevent and dissolve certain types of uroliths (e.g., struvite), enhances renal excretion of specific toxins (e.g., strontium, strychnine) or drugs (e.g., quinidine), and improves the efficacy of certain antimicrobials (like penicillins and tetracyclines) in the urinary tract. * **Metabolic Alkalosis:** Can be administered intravenously for the rapid correction of severe metabolic alkalosis. * **Clinical Pearl:** Due to the advent of highly effective struvite-dissolution diets (which inherently cause aciduria), ammonium chloride is now rarely recommended for feline struvite management. It remains a staple for urolith prevention in small ruminants, though dietary roughage-to-concentrate ratios can heavily influence its efficacy.
กลไกการออกฤทธิ์: Ammonium chloride induces acidification through hepatic metabolism: * **Dissociation:** In vivo, it dissociates into **chloride** and **ammonium** ions. * **Hepatic Conversion:** The liver converts the ammonium cation to urea, releasing a **hydrogen ion (H⁺)**. * **Acidification Pathway:** H⁺ combines with bicarbonate → H₂O + CO₂. This depletes extracellular alkaline reserves, decreasing serum bicarbonate and lowering both blood and urine pH. * **Renal Excretion:** Excess chloride ions exceed tubular reabsorption capacity and are excreted alongside cations (mainly sodium) and water, causing a mild, transient **diuretic effect**.
ขนาดยาตามชนิดสัตว์
- Urolithiasis prevention · 300 mg/kg PO · PO · Unknown
- Urolithiasis prevention · 0.5-1% of the daily dry matter · PO · Daily · Table sugar may improve palatability
- Urolithiasis prevention · 300 mg/kg PO · PO · Unknown
- Urolithiasis prevention · 0.5-1% of the daily dry matter · PO · Daily · Table sugar may improve palatability
- Struvite dissolution therapy if diet and antimicrobials do not result in acid urine or to help prevent idiopathic FUS in a non-obstructed cat · 20 mg/kg PO twice daily · PO · q12h
- Adjunctive therapy for struvite uroliths · 20 mg/kg PO twice daily · PO · q12h
- Urolithiasis prevention · 200 mg/kg PO · PO · Unknown
- Urolithiasis prevention · 15-30 grams PO · PO · Unknown
- General dosing · 4-15 grams PO · PO · Unknown
วิธีการให้ยา
ข้อห้ามใช้
- Severe hepatic disease
- Uremia
- Urate calculi
- Respiratory acidosis
- Severe renal insufficiency with metabolic alkalosis secondary to vomiting
อาการไม่พึงประสงค์
- Metabolic acidosis
- Gastric irritation
- Nausea
- Vomiting
- Pain at injection site (IV)
- Increased risk of calcium oxalate urolith formation (cats)
อันตรกิริยาระหว่างยา
- Aminoglycosides · Urine acidification may diminish effectiveness in treating bacterial urinary tract infections
- Erythromycin · Urine acidification may diminish effectiveness in treating bacterial urinary tract infections
- Quinidine · Urine acidification may increase renal excretion
การติดตาม
- Urine pH (goal is ≤6.5)
- Blood pH (if clinical signs of toxicity or treating metabolic alkalosis)
- Serum electrolytes (with chronic use or treating metabolic acidosis)
- Carbon dioxide combining power of serum (prior to IV use to prevent serious acidosis)
การได้รับยาเกินขนาด
**Clinical Signs:** Nausea, vomiting, excessive thirst, hyperventilation, bradycardia or other arrhythmias, and progressive CNS depression. Laboratory results may show profound acidosis and hypokalemia. **Treatment:** * Correct acidosis by administering sodium bicarbonate or sodium acetate intravenously. * Treat hypokalemia using a suitable oral (if possible) potassium product. * Perform intense, ongoing acid-base and electrolyte monitoring until the patient is stable.
ข้อมูลอ้างอิงยาของ VetSheet มีไว้สำหรับสัตวแพทย์ผู้มีใบอนุญาตเพื่อช่วยในการตัดสินใจทางคลินิก ไม่ใช่สิ่งทดแทนการวินิจฉัยของผู้เชี่ยวชาญหรือฉลากล่าสุดของผู้ผลิต